Primary Poster Author:
Becky Johnson, PhD, MPH photoBecky Johnson, PhD, MPH
Director, Global Diversity and Inclusion in Clinical Trials
IQVIA
Livingston, New Jersey, United States
Poster Author(s)
Michelle L. D'Abundo, PhD, MSH, CHES photoMichelle L. D'Abundo, PhD, MSH, CHES
Associate Professor
Seton Hall University
Belmar, New Jersey, United States
Poster abstract: To diversify clinical trial participation, many clinical trial organizations use strategies including education, community engagement, and the development of culturally informed recruitment materials. The purpose of this qualitative study was to understand the socio-ecological elements involved in the active implementation of racially and ethnically diverse recruitment practices for biopharmaceutical-funded trials in the US. While recognizing the importance of culture and equality in recruitment, staff interviewed still used disempowering words like “target” instead of priority population, and “subject” instead of participants. For systemic changes to occur, it is important to make inclusive, participatory language the norm in the clinical trial industry.
#LanguageCultureandIndentity
Becky Johnson, PhD, MPH photoBecky Johnson, PhD, MPH
Director, Global Diversity and Inclusion in Clinical Trials
IQVIA
Livingston, New Jersey, United States
Poster Author(s)
Michelle L. D'Abundo, PhD, MSH, CHES photoMichelle L. D'Abundo, PhD, MSH, CHES
Associate Professor
Seton Hall University
Belmar, New Jersey, United States
Poster abstract: To diversify clinical trial participation, many clinical trial organizations use strategies including education, community engagement, and the development of culturally informed recruitment materials. The purpose of this qualitative study was to understand the socio-ecological elements involved in the active implementation of racially and ethnically diverse recruitment practices for biopharmaceutical-funded trials in the US. While recognizing the importance of culture and equality in recruitment, staff interviewed still used disempowering words like “target” instead of priority population, and “subject” instead of participants. For systemic changes to occur, it is important to make inclusive, participatory language the norm in the clinical trial industry.
#LanguageCultureandIndentity